Bixiye
QP34-17 New Pre-Authorization Form for Immunoglobulin Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2661 - 2670 ee natiijooyinka 3604
Bixiye
QP4-17 APR-DRG and EAPG Grouper Discrepancy Identified
Taariikhda uu dhaqangalayo Barnaamijka: Mar 02, 2017
Bixiye
QP3-16 Free Webinar February 3, 2016: Behavioral Health Care for Refugees Barriers, Best Practices & Cultural Humility
Taariikhda uu dhaqangalayo Barnaamijka: Jan 14, 2016
Bixiye
QP24-17 Interpreter Services
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 06, 2017
Bixiye
2016 December Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2016
Bixiye
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018
Bixiye
QP42-16 Pharmacy Step Therapy Program Name Change for Anticonvulsant Agents and Update on Drugs Subject to This Step Therapy Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016
Bixiye
QP22-16 APR-DRG and EAPG Grouper Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 02, 2016
Bixiye
QP10-17 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2017
Bixiye
QP2-17 Post Hospitalization Additional Benefits for SecureBlue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2017